전체메뉴
검색
Article Search

JMB Journal of Microbiolog and Biotechnology

QR Code QR Code

Research article


References

  1. Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, French Cryptococcosis Study G. 2015. Cryptococcosis serotypes impact outcome and provide evidence of Cryptococcus neoformans speciation. mBio 6: e00311.
  2. Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES. 1993. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167: 186-190.
    Pubmed CrossRef
  3. Jacobson ES, Goodner AP, Nyhus KJ. 1998. Ferrous iron uptake in Cryptococcus neoformans. Infect. Immun. 66: 4169-4175.
    Pubmed PMC CrossRef
  4. Jung WH, Do E. 2013. Iron acquisition in the human fungal pathogen Cryptococcus neoformans. Curr. Opin. Microbiol. 16: 686-691.
    Pubmed CrossRef
  5. Caza M, Hu G, Nielson ED, Cho M, Jung WH, Kronstad JW. 2018. The Sec1/Munc18 (SM) protein Vps45 is involved in iron uptake, mitochondrial function and virulence in the pathogenic fungus Cryptococcus neoformans. PLoS Pathog. 14: e1007220.
    Pubmed PMC CrossRef
  6. Saikia S, Oliveira D, Hu G, Kronstad J. 2014. Role of ferric reductases in iron acquisition and virulence in the fungal pathogen Cryptococcus neoformans. Infect. Immun. 82: 839-850.
    Pubmed PMC CrossRef
  7. Pierrel F, Cobine PA, Winge DR. 2007. Metal Ion availability in mitochondria. Biometals 20: 675-682.
    Pubmed CrossRef
  8. Rouault TA, Tong WH. 2005. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev. Mol. Cell. Biol. 6: 345-351.
    Pubmed CrossRef
  9. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Suryo Rahmanto Y, et al. 2010. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc. Natl. Acad. Sci. USA 107: 10775-10782.
    Pubmed PMC CrossRef
  10. Napier I, Ponka P, Richardson DR. 2005. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105: 1867-1874.
    Pubmed CrossRef
  11. Hausmann A, Samans B, Lill R, Muhlenhoff U. 2008. Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis. J. Biol. Chem. 283: 8318-8330.
    Pubmed CrossRef
  12. Levi S, Rovida E. 2009. The role of iron in mitochondrial function. Biochim. Biophys. Acta 1790: 629-636.
    Pubmed CrossRef
  13. Lange H, Kispal G, Lill R. 1999. Mechanism of iron transport to the site of heme synthesis inside yeast mitochondria. J. Biol. Chem. 274: 18989-18996.
    Pubmed CrossRef
  14. Lill R, Muhlenhoff U. 2008. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 77: 669-700.
    Pubmed CrossRef
  15. Craig EA, Marszalek J. 2002. A specialized mitochondrial molecular chaperone system: a role in formation of Fe/S centers. Cell. Mol. Life Sci. 59: 1658-1665.
    Pubmed CrossRef
  16. Foury F, Roganti T. 2002. Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J. Biol. Chem. 277: 24475-24483.
    Pubmed CrossRef
  17. Zhang Y, Lyver ER, Knight SA, Lesuisse E, Dancis A. 2005. Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J. Biol. Chem. 280: 19794-19807.
    Pubmed CrossRef
  18. Kispal G, Csere P, Prohl C, Lill R. 1999. The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins. EMBO J. 18: 3981-3989.
    Pubmed PMC CrossRef
  19. Lill R, Dutkiewicz R, Freibert SA, Heidenreich T, Mascarenhas J, Netz DJ, et al. 2015. The role of mitochondria and the CIA machinery in the maturation of cytosolic and nuclear iron-sulfur proteins. Eur. J. Cell. Biol. 94: 280-291.
    Pubmed CrossRef
  20. Do E, Park S, Li MH, Wang JM, Ding C, Kronstad JW, et al. 2018. The mitochondrial ABC transporter Atm1 plays a role in iron metabolism and virulence in the human fungal pathogen Cryptococcus neoformans. Med. Mycol. 56: 458-468.
    Pubmed PMC CrossRef
  21. Jung WH, Hu G, Kuo W, Kronstad JW. 2009. Role of ferroxidases in iron uptake and virulence of Cryptococcus neoformans. Eukaryotic Cell. 8: 1511-1520.
    Pubmed PMC CrossRef
  22. Toffaletti DL, Rude TH, Johnston SA, Durack D, Perfect JR. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175: 1405-1411.
    Pubmed PMC CrossRef
  23. Sambrook J, Russell DW. 2001, pp. 6.33-6.58. Molecular cloning: a laboratory manual, 3Ed. CSHL press.
  24. Daum G, Böhni P, Schatz G. 1982. Import of proteins into mitochondria. Cytochrome b2 and cytochrome c peroxidase are located in the intermembrane space of yeast mitochondria. J. Biol. Chem. 257: 13028-13033.
  25. Gregg C, Kyryakov P, Titorenko VI. 2009. Purification of mitochondria from yeast cells. J. Vis. Exp. 30: 1417.
    Pubmed PMC CrossRef
  26. Shi Y, Ghosh MC, Tong W-H, Rouault TA. 2009. Human ISD11 is essential for both iron-sulfur cluster assembly and maintenance of normal cellular iron homeostasis. Hum. Mol. Genet. 18: 3014-3025.
    Pubmed PMC CrossRef
  27. Kim J, Cho YJ, Do E, Choi J, Hu G, Cadieux B, et al. 2012. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. Fungal Genet. Biol. 49: 955-966.
    Pubmed PMC CrossRef
  28. Jung WH, Sham A, White R, Kronstad JW. 2006. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol. 4: e410.
    Pubmed PMC CrossRef
  29. Hu G, Kronstad JW. 2010. A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans. Eukaryot. Cell. 9: 74-83.
    Pubmed PMC CrossRef
  30. Xu N, Cheng X, Yu Q, Zhang B, Ding X, Xing L, et al. 2012. Identification and functional characterization of mitochondrial carrier Mrs4 in Candida albicans. FEMS Yeast Res. 12: 844-858.
    Pubmed CrossRef
  31. Nyhus KJ, Ozaki LS, Jacobson ES. 2002. Role of mitochondrial carrier protein Mrs3/4 in iron acquisition and oxidative stress resistance of Cryptococcus neoformans. Med. Mycol. 40: 581-591.
    Pubmed CrossRef
  32. Claros MG, Vincens P. 1996. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur. J. Biochem. 241: 779-786.
    Pubmed CrossRef
  33. Jung WH, Sham A, Lian T, Singh A, Kosman DJ, Kronstad JW. 2008. Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog. 4: e45.
    Pubmed PMC CrossRef
  34. Murakami K, Yoshino M. 1997. Inactivation of aconitase in yeast exposed to oxidative stress. Biochem. Mol. Biol. Int. 41: 481-486.
    Pubmed CrossRef
  35. Do E, Hu G, Caza M, Oliveira D, Kronstad JW, Jung WH. 2015. Leu1 plays a role in iron metabolism and is required for virulence in Cryptococcus neoformans. Fungal Genet. Biol. 75: 11-19.
    Pubmed PMC CrossRef
  36. Do E, Park M, Hu G, Caza M, Kronstad JW, Jung WH. 2016. The lysine biosynthetic enzyme Lys4 influences iron metabolism, mitochondrial function and virulence in Cryptococcus neoformans. Biochem. Biophys. Res. Commun. 477: 706-711.
    Pubmed PMC CrossRef
  37. Froschauer EM, Schweyen RJ, Wiesenberger G. 2009. The yeast mitochondrial carrier proteins Mrs3p/Mrs4p mediate iron transport across the inner mitochondrial membrane. Biochim. Biophys. Acta 1788: 1044-1050.
    Pubmed CrossRef
  38. Muhlenhoff U, Stadler JA, Richhardt N, Seubert A, Eickhorst T, Schweyen RJ, et al. 2003. A specific role of the yeast mitochondrial carriers MRS3/4p in mitochondrial iron acquisition under iron-limiting conditions. J. Biol. Chem. 278: 40612-40620.
    Pubmed CrossRef
  39. Long N, Xu X, Qian H, Zhang S, Lu L. 2016. A Putative mitochondrial iron transporter MrsA in Aspergillus fumigatus plays important roles in azole-, oxidative stress responses and virulence. Front. Microbiol. 7: 716.
    CrossRef

Related articles in JMB

More Related Articles

Article

Research article

J. Microbiol. Biotechnol. 2020; 30(8): 1142-1148

Published online August 28, 2020 https://doi.org/10.4014/jmb.2004.04041

Copyright © The Korean Society for Microbiology and Biotechnology.

Involvement of Mrs3/4 in Mitochondrial Iron Transport and Metabolism in Cryptococcus neoformans

Yoojeong Choi1, Eunsoo Do1,§, Guanggan Hu2, Mélissa Caza2, James W. Kronstad2, and Won Hee Jung1,*

1Department of Systems Biotechnology, Chung-Ang University, Anseong, 17546, Republic of Korea.
2The Michael Smith Laboratories, Department of Microbiology and Immunology, University of British Columbia, Vancouver BC, V6T 1Z4, Canada.

Correspondence to:Won Hee Jung
whjung@cau.ac.kr

Received: April 19, 2020; Accepted: May 18, 2020

Abstract

Mitochondria play a vital role in iron uptake and metabolism in pathogenic fungi, and also influence virulence and drug tolerance. However, the regulation of iron transport within the mitochondria of Cryptococcus neoformans, a causative agent of fungal meningoencephalitis in immunocompromised individuals, remains largely uncharacterized. In this study, we identified and functionally characterized Mrs3/4, a homolog of the Saccharomyces cerevisiae mitochondrial iron transporter, in C. neoformans var. grubii. A strain expressing an Mrs3/4-GFP fusion protein was generated, and the mitochondrial localization of the fusion protein was confirmed. Moreover, a mutant lacking the MRS3/4 gene was constructed; this mutant displayed significantly reduced mitochondrial iron and cellular heme accumulation. In addition, impaired mitochondrial iron-sulfur cluster metabolism and altered expression of genes required for iron uptake at the plasma membrane were observed in the mrs3/4 mutant, suggesting that Mrs3/4 is involved in iron import and metabolism in the mitochondria of C. neoformans. Using a murine model of cryptococcosis, we demonstrated that an mrs3/4 mutant is defective in survival and virulence. Taken together, our study suggests that Mrs3/4 is responsible for iron import in mitochondria and reveals a link between mitochondrial iron metabolism and the virulence of C. neoformans.

Keywords: Cryptococcus neoformans, iron, iron transport, mitochondria, Mrs3/4

Introduction

Cryptococcus neoformans is a pathogenic fungus that infects humans to cause meningoencephalitis, a disease that is especially life-threatening for immunocompromised individuals. Isolates of C. neoformans are divided into two varieties (var.): C. neoformans var. grubii (capsule serotype A) and C. neoformans var. neoformans (capsule serotype D). The former is more frequently isolated from patients with cryptococcosis, shows higher virulence in experimental animal models, and includes the most commonly employed laboratory strain for studying virulence [1].

Iron is an essential nutrient for most organisms because it is a cofactor of many enzymes involved in numerous cellular processes. In C. neoformans, the importance of iron for several processes, including normal growth and pathogenesis, is well appreciated. For instance, the virulence traits of melanin synthesis and polysaccharide capsule formation are regulated by environmental iron [2]. Therefore, maintaining proper intracellular iron levels is essential for C. neoformans to meet physiological needs, particularly during host colonization. However, the level of available iron in the mammalian host is extremely low, since the majority of iron is bound to iron-binding proteins such as transferrin, lactoferrin, and hemoglobin. Upon infection, C. neoformans must overcome host iron sequestering systems to acquire iron for successful proliferation. To this end, the fungus has developed elaborate iron uptake and utilization systems, including high-affinity reductive iron uptake, siderophore transport, and heme utilization systems [3-6].

Iron acquired from the extracellular environment must be tightly regulated to avoid toxicity and it must be processed for cellular utilization by sophisticated mechanisms. In eukaryotic cells, mitochondria are not only a major consumer of iron but also play global iron regulatory roles in numerous iron metabolic processes and homeostasis [7-10]. One of the important iron metabolic processes in mitochondria is the transformation of iron to its bioactive forms, such as an iron–sulfur (Fe-S) cluster, and the mitochondria are the sole site for this process [11-13]. A model for Fe-S cluster biosynthesis has been best described in the model yeast Saccharomyces cerevisiae [8, 11, 14, 15]. The mitochondrial carrier proteins, Mrs3 and Mrs4, along with the frataxin protein Yfh1, transport iron into mitochondria [16, 17], and Fe-S clusters are assembled by a scaffold protein complex in the organelle. An unidentified form of the Fe-S cluster is then exported to the cytosol by the mitochondrial export protein Atm1 and a maturation process ensues for cytosolic utilization [18, 19].

We previously identified and characterized the mitochondrial iron exporter protein Atm1 in C. neoformans var. grubii, and we demonstrated that Atm1 is required for virulence [20]. Although a role for Atm1 iron transport has been suggested, we still do not have a comprehensive understanding of the proteins responsible for iron uptake by mitochondria in C. neoformans; this is especially true for the grubii variety.

Previously, Nyhus et al. (2002) identified the putative homolog of the S. cerevisiae mitochondrial iron importers, Mrs3 and Mrs4, in C. neoformans. However, their study focused on a limited number of phenotypes of deletion mutants, and evidence was not provided that the identified protein was localized in mitochondria or was involved in virulence in a vertebrate host. Moreover, the study was performed using C. neoformans var. neoformans and not the laboratory strain of the grubii variety that is commonly employed to study virulence. Therefore, in this study, we aimed to identify and functionally characterize the mitochondrial iron import protein (the homolog of S. cerevisiae Mrs3 and Mrs4) in C. neoformans var. grubii. Moreover, we investigated the contribution of the mitochondrial iron importer to virulence using a murine model of cryptococcosis.

Materials and Methods

Strains, Growth Conditions, and Phenotypic Analysis

C. neoformans var. grubii strain H99 (serotype A; MATα) was used for all experiments. Strains were cultured in yeast extract-bacto peptone medium containing 2.0% glucose (YPD) or defined yeast nitrogen base medium containing 2.0% glucose (YNB). To prepare low iron YNB medium, the broth was chelated using chelex-100 (Biorad, USA), its pH was adjusted to 6.8 by adding 3-morpholinopropanesulfonic acid (MOPS), and 100 μM of bathophenanthrolinedisulfonic acid (BPS) was added. For assessing phenotypes, cells were cultured in YPD at 30°C overnight, transferred to low iron medium, and cultured at 30°C for an additional 16 h to remove any intracellularly-stored iron. Cells were washed twice with chelated PBS, and cell numbers were determined using a hemocytometer. Serially diluted cells were spotted on plates and subsequently photographed after incubation at 30°C for 2 days.

Mutant Construction

The mrs3/4 knockout mutant was constructed by homologous recombination using a gene-specific disruption cassette generated by overlapping PCR. The primers used to amplify the gene specific disruption cassette, KO_1, KO_2, KO_3, KO_4, KO_5, and KO_6, were used for overlapping PCR with wild-type genomic DNA and pCH233 plasmid DNA as templates [21]. The resulting disruption cassette was introduced into the wild-type strain using biolistic transformation, as previously described [22]. Positive independent transformants were confirmed by PCR and Southern blot analysis using a probe generated with the primers Probe_F and Probe_R [23]. The MRS3/4 coding region was amplified using the Forward_HindIII and Reverse_BamHI primers and cloned into the plasmid pWH091. The resulting plasmid was linearized by KpnI digestion and introduced into the mrs3/4 mutant by biolistic transformation. All primers used in this study are listed in Table S1.

Fluorescence Microscopy

To visualize the subcellular location of the Mrs3/4-green fluorescence protein (GFP) fusion protein, the strain expressing the protein was grown in YPD medium at 30°C overnight. Cells were washed twice with iron-chelated water and resuspended with low iron YNB medium, followed by incubation at 30°C for 6 h. Mitotracker Red CMXRos (Thermo Fisher Scientific, Korea) was added to YNB medium at a final concentration of 100 nM to stain mitochondria. The cells were incubated at 30°C for 30 min and visualized using an Axioplan 2 imaging system (Zeiss, Germany) at 1,000× magnification. Differential interference contrast (DIC) and fluorescence images were obtained using the Metamorph imaging software (Universal Imaging Corporation, USA).

Mitochondrial Isolation

Isolation of mitochondria was performed using a differential centrifugation method [24]. Briefly, the strains were grown in YPD overnight at 30°C and harvested by centrifugation at 6,000 rpm for 5 min. The resulting pellet was washed twice with distilled H2O, resuspended in buffer containing 100 mM Tris-SO4, pH 9.4 and 10 mM dithiothreitol (DTT), and incubated for 10 min at 30°C. The cells were harvested by centrifugation, washed with spheroplast buffer containing 20 mg/ml of lysing enzyme (Sigma, USA), 1 M sorbitol, and 20 mM potassium phosphate buffer pH 7.4, and incubated at 37°C for 1 h. The harvested cells were washed twice with 1.2 M sorbitol, resuspended with homogenization buffer containing 0.6 M mannitol, 10 mM Tris-Cl, pH 7.4, 0.1% BSA and 1 mM phenylmethylsulfonyl fluoride (PMSF) and lysed by vortexing for 6 min. The isolation of mitochondria from cell lysates was performed as described for S. cerevisiae [25].

Determination of Intracellular Iron and Heme Levels

Mitochondrial iron levels and intracellular heme levels were respectively determined using the QuantiChrom™ Iron Assay kit (DIFE-250; BioVision, USA) and the BioVision Hemin assay kit (BioVision), following the manufacturers’ instructions.

Aconitase Activity and TTC Overlay Assays

Zymography was performed to measure the activity of aconitase as described previously [26]. The wild-type strain and the mrs3/4 mutant were grown in YPD overnight at 30°C, pelleted, and resuspended with triton/citrate lysis buffer (36.6 mM KCl, 22.9 mM Tris-Cl (pH 7.5), 1% Triton X-100, 1 mM of PMSF, 1 mM DTT, 2 mM sodium citrate and 0.6 mM MnCl2). The cells were lysed using a mini-bead beater, and total protein concentrations were measured by Bradford assay. Samples containing 20 μg of protein lysate were separated on a zymography gel at 160 V and 4°C for 2 h. The gel was visualized using aconitase-staining buffer and photographed as described previously [27]. The triphenyltetrazolium chloride (TTC; Sigma, USA) overlay assay to estimate activity of cell surface reductase was performed as described previously [28].

Virulence Assay

The virulence of the wild-type strain and the mrs3/4 mutant was assayed in a murine inhalation model of cryptococcosis using female BALB/c mice (4 to 6 weeks old) from Charles River Laboratories (Canada), as previously described [29]. Briefly, the strains were grown in 5 ml of YPD at 30°C overnight, washed twice with PBS (Invitrogen, USA), and resuspended in PBS. Groups of 10 BALB/c mice were intranasally inoculated with a suspension of 2 × 105 cells in 50 μl. The health status of the mice was monitored daily post-inoculation. Mice reaching the humane endpoint were euthanized by CO2 anoxia. Statistical analyses of survival differences were performed using log rank tests in GraphPad Prism 5 for Windows (GraphPad software, USA). The fungal load in lungs, brain, kidney, liver, spleen, and blood in ten mice was assessed at humane endpoints of the experiment. Organs were aseptically removed, weighed, homogenized, and diluted in PBS prior to inoculation on YPD plates. Blood was retrieved from the heart and directly inoculated onto YPD plates. Plates were incubated at 30°C for 48 h and CFU counts were determined. Virulence assay protocols (protocol A17-0117) were approved by the University of British Columbia Committee on Animal Care.

Results

Identification of the Mitochondrial Iron Transporter Mrs3/4 in C. neoformans var. grubii

To identify potential orthologs of the S. cerevisiae Mrs3 and Mrs4 proteins in the grubii variety of C. neoformans, we carried out BLASTp analysis using the fungal genome database (http://www.fungidb.org). A single gene, CNAG_02522, was identified to encode the homolog of both S. cerevisiae Mrs3 and Mrs4, with respective identities of 46% and 44%. CNAG_02522 was also homologous with the Candida albicans genes encoding the Mrs3 and Mrs4 proteins [30] and the C. neoformans var. neoformans Mrs3/4 homolog (Genbank AY048991), which was identified in a previous study [31]. Analysis of the protein sequence encoded by CNAG_02522 using Mitoprot II revealed a mitochondrial targeting sequence and a cleavage site in the N-terminal region [32]. Since no other homolog was identified, we concluded that CNAG_02522 is the only homolog of S. cerevisiae Mrs3 and Mrs4 and therefore designated it Mrs3/4.

Functional Characterization of Mrs3/4

To investigate the functional characteristics of Mrs3/4 in C. neoformans, we constructed an MRS3/4 knockout mutant using biolistic transformation and confirmed complete deletion of the MRS3/4 coding region by Southern blot analysis (Fig. 1). There was no difference between the growth of the wild-type strain and the mrs3/4 mutant in rich medium, and capsule synthesis and melanin formation in the mutant cells were also similar to the wild-type cells (data not shown). However, the mrs3/4 mutant showed delayed growth upon iron depletion (Fig. 2A). Furthermore, the growth defect induced by iron depletion was reversed by adding exogenous iron sources, such as FeCl3, the siderophore ferroxamine, or heme, suggesting that iron transport and metabolism are deficient in the mutant (Fig. 2A). We next investigated if the deficiencies in iron transport and metabolism in the mrs3/4 mutant are caused by altered expression of genes required for iron uptake. The CFO1, FRE2, and SIT1 genes encode proteins responsible for high-affinity iron uptake or siderophore transport at the cell membrane, and we evaluated for their transcript levels in the wild-type strain and the mutant. The results presented in Fig. 2B show that, indeed, the CFO1, FRE2, and SIT1 transcript levels were significantly increased in the mrs3/4 mutant. We hypothesized that mitochondrial iron is depleted in the mrs3/4 mutant cells and, consequently, the upregulation of genes involved in iron uptake at the cell surface was triggered. Upregulation of these genes was further supported by increased cell surface reductase activity as visualized with TTC overlay, a phenotype also observed in a mutant lacking the major iron regulator Cir1 that positively regulates the high affinity iron uptake system in C. neoformans (Fig. 2C) [33].

Figure 1. Construction of the mrs3/4 mutant. (A) To confirm the disruption of MRS3/4, genomic DNA from the wild-type strain and the mrs3/4 mutant was digested with Xho1/SacI and hybridized with the indicated probes. (B) Southern blot analysis indicated genomic deletion of MRS3/4. Two independent mrs3/4 mutants (#1 and #2) were constructed, and #1 was used throughout the study.
Figure 2. Iron transport and metabolism deficiencies in the mrs3/4 mutant. (A) The growth of the mrs3/4 mutant in low-iron YNB media (LIM) containing various iron sources was monitored. Ten-fold serial dilutions of cells (starting at 104 cells) were spotted onto the plates and incubated at 30°C for 2 days. (B) The transcript levels of CFO1, FRE2, and SIT1 were determined using qRT-PCR. Data were normalized using TEF2 as an internal control and represent the average from three independent experiments (with standard deviations indicated). (C) Measurement of ferric reductase activity was carried out using a TCC overlay assay. TCC was poured on spotted cells and plates were photographed after 10 min.

Localization and Role of Mrs3/4 in C. neoformans var. grubii

In S. cerevisiae, Mrs3 and Mrs4 import iron at the inner mitochondrial membrane. To confirm mitochondrial localization of Mrs3/4 in C. neoformans, we constructed a strain expressing the Mrs3/4 protein fused with GFP and observed the localization of the fusion protein by fluorescence microscopy. As shown in Fig. 3A, the Mrs3/4- GFP signal overlapped with the Mitotracker (mitochondria) signal, confirming mitochondrial localization of the Mrs3/4-GFP fusion protein.

Figure 3. Mitochondrial localization of the Mrs3/4 protein and impaired mitochondrial iron metabolism in the mrs3/4 mutant. (A)) The strain expressing the Mrs3/4-GFP fusion protein was stained with 100 nM of Mitotracker to visualize mitochondria. The scale bar represents 5 μm. Iron contents of isolated mitochondria (B) and total intracellular heme contents (C) were determined by colorimetric assays. Values indicate iron or heme contents relative to those of the wild-type and represent the average from three independent experiments, with standard deviations. (D) The activity of aconitase was determined using in-gel assays, and the intensity of each band was quantified. CPTA (copper phthalocyanine-3, 4', 4", 4'"- tetrasulfonic acid tetrasodium) shows equal sample loading. All experiments were carried out in triplicate.

Based on the results presented above and the role of Mrs3/4 as a mitochondrial iron importer in S. cerevisiae, we hypothesized that the mrs3/4 mutant might have an impaired ability to accumulate iron in mitochondria. To test our hypothesis, mitochondria were isolated from the mrs3/4 mutant and the wild-type strain, and the mitochondrial iron content was measured and compared. Mitochondria isolated from the mrs3/4 mutant had lower iron levels compared with those of wild-type mitochondria (63.65% of wild-type (p < 0.01)) (Fig. 3B). Moreover, we measured the levels of intracellular heme, an important iron-containing molecule in mitochondria, and found that heme levels dropped to 44.24% of wild-type levels in the mrs3/4 mutant (p < 0.001) (Fig. 3C). Aconitase is a mitochondrial protein that uses Fe-S clusters as a co-factor, and its enzymatic activity is a well- known marker of mitochondrial Fe-S cluster biosynthesis [20, 34]. Therefore, we measured aconitase activity in the mrs3/4 mutant and compared it to the wild-type strain. A zymography assay revealed that the aconitase activity in the mrs3/4 mutant was reduced to 48.76% of wild type (Fig. 3D). Expression of the Mrs3/4-GFP fusion protein in the deletion mutant complemented the defects in heme levels and aconitase activity, thereby providing support for both the impact of the mrs3/4 deletion on the observed phenotypes and the functionality of the fusion protein. Overall, our data indicate that Mrs3/4 is a mitochondrial protein and that deletion of MRS3/4 causes a significant deficiency in mitochondrial iron metabolism (e.g., heme and Fe-S cluster biosynthesis), which is likely due to defects in mitochondrial iron uptake.

Analysis of the Requirement of Mrs3/4 for Virulence in a Murine Model of Cryptococcosis

Iron metabolism and mitochondrial functions are critical for the survival and virulence of C. neoformans within a vertebrate host [20, 35, 36]. Therefore, we examined the differences in the survival and virulence of the mrs3/4 mutant and the wild type in a murine inhalation model of cryptococcosis. The mice infected with the mrs3/4 mutant survived until the end of the experiments, while mice infected with the wild type survived only until 10 days post-infection (Fig. 4A). We examined reduction in the virulence of the mrs3/4 mutant in more detail by assessing the fungal burden in the organs of infected mice. This was accomplished by measuring the number of fungal colony forming units (CFUs) present in the organs at the humane endpoint. As shown in Fig. 4B, the CFUs of the mrs3/4 mutant were significantly reduced in each organ compared to those of the wild type, suggesting that Mrs3/4 is required for the proliferation and survival of the fungus in mice.

Figure 4. Requirement of MRS3/4 for virulence in a mouse inhalation model. (A) Ten female BALB/c mice were intranasally infected with each of the strains indicated, and mouse survival was monitored twice per day. The results from the assays indicate that MRS3/4 is required for full virulence. (B) The distribution of fungal cells in the organs (blood, kidney, spleen, brain, lung, and liver) of infected mice. Organs from wild-type and mrs3/4 mutant infected mice were collected at the humane endpoint of the experiment, and fungal burdens were quantified by CFUs. In all organs, differences in fungal burden between the wild-type and the mrs3/4 mutant were statistically significant, as assessed by a nonparametric two-tailed Mann- Whitney U test (*p < 0.05; **p < 0.001).

Discussion

In this study, we identified and functionally characterized Mrs3/4 in the grubii variety of C. neoformans. Mrs3/ 4 is the homolog of the S. cerevisiae Mrs3 and Mrs4 proteins, which are solute carrier proteins located at the mitochondrial inner membrane that import iron into mitochondria [37, 38]. It has been suggested that Mrs3 and Mrs4, along with frataxin Yfh1, cooperatively provide iron for heme and Fe-S cluster biosynthesis in S. cerevisiae mitochondria [16, 17]. Furthermore, loss of an Aspergillus fumigatus homolog of S. cerevisiae Mrs3 and Mrs4 (MrsA) resulted in delayed growth under iron-limiting conditions and attenuated virulence [39].

Nyhus et al. (2002) previously identified an MRS3/4 gene in C. neoformans var. neoformans, and found that the gene complemented mutations in the OXY1 and FRR1 genes, which cause constitutively high reductase activity and increased intracellular iron accumulation. The conclusion from this study was that OXY1 and FRR1 represent alleles of the same gene complemented by MRS3/4, and that the predicted amino acid sequence of C. neoformans var. neoformans Mrs3/4 was homologous to the Mrs3 and Mrs4 proteins of S. cerevisiae. Additionally, it was found that disruption of the MRS3/4 gene increased reductase activity and total intracellular iron accumulation, and caused a slow growth phenotype in the mutant cells under iron-limiting conditions. While Nyhus et al. (2002) found increased total intracellular iron levels in the mrs3/4 mutant, we observed significantly reduced iron levels in isolated mitochondria from the mutant. The results of these observations suggest that deletion of MRS3/4 reduced iron accumulation in mitochondria, and that iron deprivation within mitochondria induced iron uptake at the cellular membrane leading to increased iron levels in the cytoplasm. Our results also suggested that Mrs3/4 indeed plays a role in iron transport at the interface between the cytosol and mitochondria to regulate iron compartmentalization in C. neoformans, and that mitochondria play a central role in controlling intracellular iron homeostasis. We should note that our findings of reduced iron levels in isolated mitochondria from the mrs3/4 mutant, and reduced intracellular heme content and Fe-S biosynthesis in the mutant cells, agree well with the findings for the S. cerevisiae mrs3 and mrs4 mutants [37, 38].

Although functions related to iron transport and metabolism were observed in the study by Nyhus et al. (2002), experimental confirmation that Mrs3/4 is indeed a mitochondrial protein responsible for iron import was not provided. Here, we clearly showed that Mrs3/4 is localized in the mitochondria of C. neoformans var. grubii and that loss of MRS3/4 caused growth defects in this variety under iron-limiting conditions. Deletion of MRS3/4 also caused a significant reduction in mitochondrial iron accumulation and deficiency in mitochondrial iron metabolism (heme and Fe-S cluster biosynthesis) [11-13]. In S. cerevisiae, Fe-S clusters are assembled by a scaffold protein complex within mitochondria, followed by export of the molecules to the cytosol by the mitochondrial iron exporter protein Atm1, the C. neoformans homolog of which was identified and functionally characterized in our previous study [20]. The C. neoformans mutant strain lacking ATM1 showed significantly increased mitochondrial iron accumulation, which also led to the disruption of mitochondrial iron homeostasis and impairment of the cytosolic Fe-S cluster maturation machinery. The results of the current study suggest that Mrs3/ 4, as an iron importer, may play opposing roles to Atm1 in mitochondrial iron metabolism in C. neoformans.

Importantly, no studies have yet investigated whether Mrs3/4 influences the survival and virulence of C. neoformans in a vertebrate host. Our study revealed that Mrs3/4 is required for the virulence of C. neoformans var. grubii in a murine model of cryptococcosis. Our data are in agreement with the results for A. fumigatus in which loss of MrsA, the homolog of Mrs3/4, resulted in delayed growth under iron-limiting conditions and attenuated virulence [39]. Taken together, the results indicate that the role of Mrs3/4 is highly conserved in pathogenic fungi and that mitochondrial iron uptake and metabolism are critical to fungal pathogenesis.

Supplemental Material

Acknowledgment

This research was supported by the Chung-Ang University Research Grants in 2018 (to W. J.) and by the grant (5R01 AI053721) from the National Institute of Allergy and Infectious Diseases (to J.W. K.)

Conflict of Interest

The authors have no financial conflicts of interest to declare.

Fig 1.

Figure 1.Construction of the mrs3/4 mutant. (A) To confirm the disruption of MRS3/4, genomic DNA from the wild-type strain and the mrs3/4 mutant was digested with Xho1/SacI and hybridized with the indicated probes. (B) Southern blot analysis indicated genomic deletion of MRS3/4. Two independent mrs3/4 mutants (#1 and #2) were constructed, and #1 was used throughout the study.
Journal of Microbiology and Biotechnology 2020; 30: 1142-1148https://doi.org/10.4014/jmb.2004.04041

Fig 2.

Figure 2.Iron transport and metabolism deficiencies in the mrs3/4 mutant. (A) The growth of the mrs3/4 mutant in low-iron YNB media (LIM) containing various iron sources was monitored. Ten-fold serial dilutions of cells (starting at 104 cells) were spotted onto the plates and incubated at 30°C for 2 days. (B) The transcript levels of CFO1, FRE2, and SIT1 were determined using qRT-PCR. Data were normalized using TEF2 as an internal control and represent the average from three independent experiments (with standard deviations indicated). (C) Measurement of ferric reductase activity was carried out using a TCC overlay assay. TCC was poured on spotted cells and plates were photographed after 10 min.
Journal of Microbiology and Biotechnology 2020; 30: 1142-1148https://doi.org/10.4014/jmb.2004.04041

Fig 3.

Figure 3.Mitochondrial localization of the Mrs3/4 protein and impaired mitochondrial iron metabolism in the mrs3/4 mutant. (A)) The strain expressing the Mrs3/4-GFP fusion protein was stained with 100 nM of Mitotracker to visualize mitochondria. The scale bar represents 5 μm. Iron contents of isolated mitochondria (B) and total intracellular heme contents (C) were determined by colorimetric assays. Values indicate iron or heme contents relative to those of the wild-type and represent the average from three independent experiments, with standard deviations. (D) The activity of aconitase was determined using in-gel assays, and the intensity of each band was quantified. CPTA (copper phthalocyanine-3, 4', 4", 4'"- tetrasulfonic acid tetrasodium) shows equal sample loading. All experiments were carried out in triplicate.
Journal of Microbiology and Biotechnology 2020; 30: 1142-1148https://doi.org/10.4014/jmb.2004.04041

Fig 4.

Figure 4.Requirement of MRS3/4 for virulence in a mouse inhalation model. (A) Ten female BALB/c mice were intranasally infected with each of the strains indicated, and mouse survival was monitored twice per day. The results from the assays indicate that MRS3/4 is required for full virulence. (B) The distribution of fungal cells in the organs (blood, kidney, spleen, brain, lung, and liver) of infected mice. Organs from wild-type and mrs3/4 mutant infected mice were collected at the humane endpoint of the experiment, and fungal burdens were quantified by CFUs. In all organs, differences in fungal burden between the wild-type and the mrs3/4 mutant were statistically significant, as assessed by a nonparametric two-tailed Mann- Whitney U test (*p < 0.05; **p < 0.001).
Journal of Microbiology and Biotechnology 2020; 30: 1142-1148https://doi.org/10.4014/jmb.2004.04041

References

  1. Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, French Cryptococcosis Study G. 2015. Cryptococcosis serotypes impact outcome and provide evidence of Cryptococcus neoformans speciation. mBio 6: e00311.
  2. Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES. 1993. Regulation of cryptococcal capsular polysaccharide by iron. J. Infect. Dis. 167: 186-190.
    Pubmed CrossRef
  3. Jacobson ES, Goodner AP, Nyhus KJ. 1998. Ferrous iron uptake in Cryptococcus neoformans. Infect. Immun. 66: 4169-4175.
    Pubmed KoreaMed CrossRef
  4. Jung WH, Do E. 2013. Iron acquisition in the human fungal pathogen Cryptococcus neoformans. Curr. Opin. Microbiol. 16: 686-691.
    Pubmed CrossRef
  5. Caza M, Hu G, Nielson ED, Cho M, Jung WH, Kronstad JW. 2018. The Sec1/Munc18 (SM) protein Vps45 is involved in iron uptake, mitochondrial function and virulence in the pathogenic fungus Cryptococcus neoformans. PLoS Pathog. 14: e1007220.
    Pubmed KoreaMed CrossRef
  6. Saikia S, Oliveira D, Hu G, Kronstad J. 2014. Role of ferric reductases in iron acquisition and virulence in the fungal pathogen Cryptococcus neoformans. Infect. Immun. 82: 839-850.
    Pubmed KoreaMed CrossRef
  7. Pierrel F, Cobine PA, Winge DR. 2007. Metal Ion availability in mitochondria. Biometals 20: 675-682.
    Pubmed CrossRef
  8. Rouault TA, Tong WH. 2005. Iron-sulphur cluster biogenesis and mitochondrial iron homeostasis. Nat. Rev. Mol. Cell. Biol. 6: 345-351.
    Pubmed CrossRef
  9. Richardson DR, Lane DJ, Becker EM, Huang ML, Whitnall M, Suryo Rahmanto Y, et al. 2010. Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol. Proc. Natl. Acad. Sci. USA 107: 10775-10782.
    Pubmed KoreaMed CrossRef
  10. Napier I, Ponka P, Richardson DR. 2005. Iron trafficking in the mitochondrion: novel pathways revealed by disease. Blood 105: 1867-1874.
    Pubmed CrossRef
  11. Hausmann A, Samans B, Lill R, Muhlenhoff U. 2008. Cellular and mitochondrial remodeling upon defects in iron-sulfur protein biogenesis. J. Biol. Chem. 283: 8318-8330.
    Pubmed CrossRef
  12. Levi S, Rovida E. 2009. The role of iron in mitochondrial function. Biochim. Biophys. Acta 1790: 629-636.
    Pubmed CrossRef
  13. Lange H, Kispal G, Lill R. 1999. Mechanism of iron transport to the site of heme synthesis inside yeast mitochondria. J. Biol. Chem. 274: 18989-18996.
    Pubmed CrossRef
  14. Lill R, Muhlenhoff U. 2008. Maturation of iron-sulfur proteins in eukaryotes: mechanisms, connected processes, and diseases. Annu. Rev. Biochem. 77: 669-700.
    Pubmed CrossRef
  15. Craig EA, Marszalek J. 2002. A specialized mitochondrial molecular chaperone system: a role in formation of Fe/S centers. Cell. Mol. Life Sci. 59: 1658-1665.
    Pubmed CrossRef
  16. Foury F, Roganti T. 2002. Deletion of the mitochondrial carrier genes MRS3 and MRS4 suppresses mitochondrial iron accumulation in a yeast frataxin-deficient strain. J. Biol. Chem. 277: 24475-24483.
    Pubmed CrossRef
  17. Zhang Y, Lyver ER, Knight SA, Lesuisse E, Dancis A. 2005. Frataxin and mitochondrial carrier proteins, Mrs3p and Mrs4p, cooperate in providing iron for heme synthesis. J. Biol. Chem. 280: 19794-19807.
    Pubmed CrossRef
  18. Kispal G, Csere P, Prohl C, Lill R. 1999. The mitochondrial proteins Atm1p and Nfs1p are essential for biogenesis of cytosolic Fe/S proteins. EMBO J. 18: 3981-3989.
    Pubmed KoreaMed CrossRef
  19. Lill R, Dutkiewicz R, Freibert SA, Heidenreich T, Mascarenhas J, Netz DJ, et al. 2015. The role of mitochondria and the CIA machinery in the maturation of cytosolic and nuclear iron-sulfur proteins. Eur. J. Cell. Biol. 94: 280-291.
    Pubmed CrossRef
  20. Do E, Park S, Li MH, Wang JM, Ding C, Kronstad JW, et al. 2018. The mitochondrial ABC transporter Atm1 plays a role in iron metabolism and virulence in the human fungal pathogen Cryptococcus neoformans. Med. Mycol. 56: 458-468.
    Pubmed KoreaMed CrossRef
  21. Jung WH, Hu G, Kuo W, Kronstad JW. 2009. Role of ferroxidases in iron uptake and virulence of Cryptococcus neoformans. Eukaryotic Cell. 8: 1511-1520.
    Pubmed KoreaMed CrossRef
  22. Toffaletti DL, Rude TH, Johnston SA, Durack D, Perfect JR. 1993. Gene transfer in Cryptococcus neoformans by use of biolistic delivery of DNA. J. Bacteriol. 175: 1405-1411.
    Pubmed KoreaMed CrossRef
  23. Sambrook J, Russell DW. 2001, pp. 6.33-6.58. Molecular cloning: a laboratory manual, 3Ed. CSHL press.
  24. Daum G, Böhni P, Schatz G. 1982. Import of proteins into mitochondria. Cytochrome b2 and cytochrome c peroxidase are located in the intermembrane space of yeast mitochondria. J. Biol. Chem. 257: 13028-13033.
  25. Gregg C, Kyryakov P, Titorenko VI. 2009. Purification of mitochondria from yeast cells. J. Vis. Exp. 30: 1417.
    Pubmed KoreaMed CrossRef
  26. Shi Y, Ghosh MC, Tong W-H, Rouault TA. 2009. Human ISD11 is essential for both iron-sulfur cluster assembly and maintenance of normal cellular iron homeostasis. Hum. Mol. Genet. 18: 3014-3025.
    Pubmed KoreaMed CrossRef
  27. Kim J, Cho YJ, Do E, Choi J, Hu G, Cadieux B, et al. 2012. A defect in iron uptake enhances the susceptibility of Cryptococcus neoformans to azole antifungal drugs. Fungal Genet. Biol. 49: 955-966.
    Pubmed KoreaMed CrossRef
  28. Jung WH, Sham A, White R, Kronstad JW. 2006. Iron regulation of the major virulence factors in the AIDS-associated pathogen Cryptococcus neoformans. PLoS Biol. 4: e410.
    Pubmed KoreaMed CrossRef
  29. Hu G, Kronstad JW. 2010. A putative P-type ATPase, Apt1, is involved in stress tolerance and virulence in Cryptococcus neoformans. Eukaryot. Cell. 9: 74-83.
    Pubmed KoreaMed CrossRef
  30. Xu N, Cheng X, Yu Q, Zhang B, Ding X, Xing L, et al. 2012. Identification and functional characterization of mitochondrial carrier Mrs4 in Candida albicans. FEMS Yeast Res. 12: 844-858.
    Pubmed CrossRef
  31. Nyhus KJ, Ozaki LS, Jacobson ES. 2002. Role of mitochondrial carrier protein Mrs3/4 in iron acquisition and oxidative stress resistance of Cryptococcus neoformans. Med. Mycol. 40: 581-591.
    Pubmed CrossRef
  32. Claros MG, Vincens P. 1996. Computational method to predict mitochondrially imported proteins and their targeting sequences. Eur. J. Biochem. 241: 779-786.
    Pubmed CrossRef
  33. Jung WH, Sham A, Lian T, Singh A, Kosman DJ, Kronstad JW. 2008. Iron source preference and regulation of iron uptake in Cryptococcus neoformans. PLoS Pathog. 4: e45.
    Pubmed KoreaMed CrossRef
  34. Murakami K, Yoshino M. 1997. Inactivation of aconitase in yeast exposed to oxidative stress. Biochem. Mol. Biol. Int. 41: 481-486.
    Pubmed CrossRef
  35. Do E, Hu G, Caza M, Oliveira D, Kronstad JW, Jung WH. 2015. Leu1 plays a role in iron metabolism and is required for virulence in Cryptococcus neoformans. Fungal Genet. Biol. 75: 11-19.
    Pubmed KoreaMed CrossRef
  36. Do E, Park M, Hu G, Caza M, Kronstad JW, Jung WH. 2016. The lysine biosynthetic enzyme Lys4 influences iron metabolism, mitochondrial function and virulence in Cryptococcus neoformans. Biochem. Biophys. Res. Commun. 477: 706-711.
    Pubmed KoreaMed CrossRef
  37. Froschauer EM, Schweyen RJ, Wiesenberger G. 2009. The yeast mitochondrial carrier proteins Mrs3p/Mrs4p mediate iron transport across the inner mitochondrial membrane. Biochim. Biophys. Acta 1788: 1044-1050.
    Pubmed CrossRef
  38. Muhlenhoff U, Stadler JA, Richhardt N, Seubert A, Eickhorst T, Schweyen RJ, et al. 2003. A specific role of the yeast mitochondrial carriers MRS3/4p in mitochondrial iron acquisition under iron-limiting conditions. J. Biol. Chem. 278: 40612-40620.
    Pubmed CrossRef
  39. Long N, Xu X, Qian H, Zhang S, Lu L. 2016. A Putative mitochondrial iron transporter MrsA in Aspergillus fumigatus plays important roles in azole-, oxidative stress responses and virulence. Front. Microbiol. 7: 716.
    CrossRef